Influenza A virus M2 (matrix protein) antibody

Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites.

Displaying and delivering viral membrane antigens via WW domain-activated extracellular vesicles.

SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus.

MicroRNA let-7 Suppresses Influenza A Virus Infection by Targeting RPS16 and Enhancing Type I Interferon Response.

PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence. Wang G et al., 2022 Apr, PLoS Pathog

Subtractive CRISPR screen identifies the ATG16L1/vacuolar ATPase axis as required for non-canonical LC3 lipidation. Ulferts R et al., 2021 Oct 26, Cell Rep

Essential Oil-Rich Chinese Formula Luofushan-Baicao Oil Inhibits the Infection of Influenza A Virus through the Regulation of NF-kappaB P65 and IRF3 Activation. Mao X et al., 2021, Evid Based Complement Alternat Med

Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Hara H et al., 2021 May 12, Sci Rep

8-O-(E-p-methoxycinnamoyl)harpagide Inhibits Influenza A Virus Infection by Suppressing Intracellular Calcium. Kwon EB et al., 2021 Feb 15, Molecules

Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. Chida J et al., 2020 Aug, PLoS Pathog